ExcelMale
Menu
Home
What's new
Latest activity
Forums
New posts
Search forums
What's new
New posts
Latest activity
Videos
Lab Tests
Doctor Finder
Buy Books
About Us
Men’s Health Coaching
Log in
Register
What's new
Search
Search
Search titles only
By:
New posts
Search forums
Menu
Log in
Register
Navigation
Install the app
Install
More options
Contact us
Close Menu
Forums
Testosterone Replacement, Low T, HCG, & Beyond
Testosterone and Men's Health Articles
TRT and Electrocardiograph Findings
JavaScript is disabled. For a better experience, please enable JavaScript in your browser before proceeding.
You are using an out of date browser. It may not display this or other websites correctly.
You should upgrade or use an
alternative browser
.
Reply to thread
Message
<blockquote data-quote="CoastWatcher" data-source="post: 82287" data-attributes="member: 2624"><p>It has been known that endogenous testosterone levels have been negatively associated with the QTc interval in the ECG in some small studies; the effects of TRT on electrocardiograph parameters had not been evaluated in randomized trials until recently.</p><p></p><p>Effects of Testosterone Replacement on Electrocardiographic Parameters in Men: Findings from Two Randomized Trials appeared in the December 2016 issue of "The Journal of Clinical Endocrinology & Metabolism." </p><p></p><ul> <li data-xf-list-type="ul">Men with pre- and post-randomization electrocardiograms (ECGs) from the Testosterone and Pain (TAP) and the Testosterone Effects on Atherosclerosis in Aging Men (TEAAM) Trials were randomized to either placebo or testosterone gel for 14 weeks (TAP) or 36 months (TEAAM).</li> <li data-xf-list-type="ul">ECGs were performed at baseline and at the end of interventions in both trials; in the TEAAM trial ECGs were also obtained at 12 and 24 months.</li> <li data-xf-list-type="ul">Mean total testosterone levels increased in the testosterone group of both trials. In the TAP trial, there was a nonsignificant reduction in mean QTcF in the testosterone group compared with placebo. In the TEAAM trial, testosterone attenuated the age-related increase in QTcF seen in the placebo group (effect size= &#8722;6.30 ms; <em>P</em> < 0.001).</li> </ul><p></p><p>The researchers concluded that Testosterone replacement attenuated the age-related increase in QTcF duration in men. But they appended the typical caveat - the clinical implications of these findings require further investigation. It should be noted that it was topical testosterone that was used in these trials (gels), rather than injectable testosterone.</p><p></p><p><a href="https://academic.oup.com/jcem/article-abstract/102/5/1478/3797298/Effects-of-Testosterone-Replacement-on?redirectedFrom=fulltext" target="_blank">https://academic.oup.com/jcem/article-abstract/102/5/1478/3797298/Effects-of-Testosterone-Replacement-on?redirectedFrom=fulltext</a></p></blockquote><p></p>
[QUOTE="CoastWatcher, post: 82287, member: 2624"] It has been known that endogenous testosterone levels have been negatively associated with the QTc interval in the ECG in some small studies; the effects of TRT on electrocardiograph parameters had not been evaluated in randomized trials until recently. Effects of Testosterone Replacement on Electrocardiographic Parameters in Men: Findings from Two Randomized Trials appeared in the December 2016 issue of "The Journal of Clinical Endocrinology & Metabolism." [LIST=|INDENT=2] [*]Men with pre- and post-randomization electrocardiograms (ECGs) from the Testosterone and Pain (TAP) and the Testosterone Effects on Atherosclerosis in Aging Men (TEAAM) Trials were randomized to either placebo or testosterone gel for 14 weeks (TAP) or 36 months (TEAAM). [*]ECGs were performed at baseline and at the end of interventions in both trials; in the TEAAM trial ECGs were also obtained at 12 and 24 months. [*]Mean total testosterone levels increased in the testosterone group of both trials. In the TAP trial, there was a nonsignificant reduction in mean QTcF in the testosterone group compared with placebo. In the TEAAM trial, testosterone attenuated the age-related increase in QTcF seen in the placebo group (effect size= −6.30 ms; [I]P[/I] < 0.001). [/LIST] The researchers concluded that Testosterone replacement attenuated the age-related increase in QTcF duration in men. But they appended the typical caveat - the clinical implications of these findings require further investigation. It should be noted that it was topical testosterone that was used in these trials (gels), rather than injectable testosterone. [URL]https://academic.oup.com/jcem/article-abstract/102/5/1478/3797298/Effects-of-Testosterone-Replacement-on?redirectedFrom=fulltext[/URL] [/QUOTE]
Insert quotes…
Verification
Post reply
Share this page
Facebook
Twitter
Reddit
Pinterest
Tumblr
WhatsApp
Email
Share
Link
Sponsors
Forums
Testosterone Replacement, Low T, HCG, & Beyond
Testosterone and Men's Health Articles
TRT and Electrocardiograph Findings
This site uses cookies to help personalise content, tailor your experience and to keep you logged in if you register.
By continuing to use this site, you are consenting to our use of cookies.
Accept
Learn more…
Top